What are the objectives of treatment for intestinal lymphangiectasia?
Takahashi
H
H
Imai
K
K
D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008201:Lymphangiectasis, Intestinal / Q000188:drug therapy*; D015282:Octreotide / Q000627:therapeutic use*
D005765:Gastrointestinal Agents; D015282:Octreotide